全文获取类型
收费全文 | 2637篇 |
免费 | 288篇 |
出版年
2022年 | 15篇 |
2021年 | 26篇 |
2020年 | 18篇 |
2019年 | 20篇 |
2018年 | 30篇 |
2017年 | 35篇 |
2016年 | 58篇 |
2015年 | 81篇 |
2014年 | 94篇 |
2013年 | 126篇 |
2012年 | 137篇 |
2011年 | 153篇 |
2010年 | 102篇 |
2009年 | 90篇 |
2008年 | 124篇 |
2007年 | 136篇 |
2006年 | 105篇 |
2005年 | 105篇 |
2004年 | 102篇 |
2003年 | 112篇 |
2002年 | 90篇 |
2001年 | 80篇 |
2000年 | 107篇 |
1999年 | 88篇 |
1998年 | 32篇 |
1997年 | 45篇 |
1996年 | 37篇 |
1995年 | 38篇 |
1994年 | 38篇 |
1993年 | 37篇 |
1992年 | 58篇 |
1991年 | 57篇 |
1990年 | 60篇 |
1989年 | 47篇 |
1988年 | 32篇 |
1987年 | 35篇 |
1986年 | 48篇 |
1985年 | 34篇 |
1984年 | 17篇 |
1983年 | 19篇 |
1982年 | 22篇 |
1981年 | 19篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1976年 | 18篇 |
1975年 | 14篇 |
1974年 | 13篇 |
1973年 | 16篇 |
1972年 | 21篇 |
1970年 | 15篇 |
排序方式: 共有2925条查询结果,搜索用时 62 毫秒
921.
922.
923.
Óscar López Feng-Ling Qing Christian Marcus Pedersen Mikael Bols 《Bioorganic & medicinal chemistry》2013,21(16):4755-4761
Imino- and azasugar glycosidase inhibitors display pH dependant inhibition reflecting that both the inhibitor and the enzyme active site have groups that change protonation state with pH. With the enzyme having two acidic groups and the inhibitor one basic group, enzyme–inhibitor complexes with three (EH3I), two (EH2I), one (EHI), or no protons (EI), are possible. In the present work an analysis method is presented that from pH-inhibition data allows one to distinguish between the different complexes and determine which protonation state is preferred. It is also possible to determine the pH-independent binding constants of the inhibitor. Analysis of pH data for imino- and azasugar inhibition of β-glucosidases revealed that basic glycosidase inhibitors bind as the monoprotonated (EHI) complex. Three neutral inhibitors were also studied and two of these were also bound exclusively as the EHI complex while a third bound both as a EHI and a EH2I complex. 相似文献
924.
925.
Louise Berkhoudt Lassen Annette Füchtbauer Alexander Schmitz Annette Balle Sørensen Finn Skou Pedersen Ernst-Martin Füchtbauer 《Cell and tissue research》2013,352(3):695-705
SEPTIN9 (SEPT9) is a filament-forming protein involved in numerous cellular processes. We have used a conditional knock out allele of Sept9 to specifically delete Sept9 in T-cells. As shown by fluorescence-activated cell sorting, loss of Sept9 at an early thymocyte stage in the thymus results in increased numbers of double-negative cells indicating that SEPT9 is involved in the transition from the double-negative stage during T-cell development. Accordingly, the relative numbers of mature T-cells in the periphery are decreased in mice with a T-cell-specific deletion of Sept9. Proliferation of Sept9-deleted CD8+ T-cells from the spleen is decreased upon stimulation in culture. The altered T-cell homeostasis caused by the loss of Sept9 results in an increase of CD8+ central memory T-cells. 相似文献
926.
P-Type ATPases are part of the regulatory system of the cell where they are responsible for transporting ions and lipids through the cell membrane. These pumps are found in all eukaryotes and their malfunction has been found to cause several severe diseases. Knowing which substrate is pumped by a certain P-Type ATPase is therefore vital. The P-Type ATPases can be divided into 11 subtypes based on their specificity, that is, the substrate that they pump. Determining the subtype experimentally is time-consuming. Thus it is of great interest to be able to accurately predict the subtype based on the amino acid sequence only. We present an approach to P-Type ATPase sequence classification based on the k-nearest neighbors, similar to a homology search, and show that this method provides performs very well and, to the best of our knowledge, better than any existing method despite its simplicity. The classifier is made available as a web service at http://services.birc.au.dk/patbox/ which also provides access to a database of potential P-Type ATPases and their predicted subtypes. 相似文献
927.
928.
Sameer D. Pant Peter Karlskov-Mortensen Mette J. Jacobsen Susanna Cirera Lisette J. A. Kogelman Camilla S. Bruun Thomas Mark Claus B. J?rgensen Niels Grarup Emil V. R. Appel Ehm A. A. Galjatovic Torben Hansen Oluf Pedersen Maryse Guerin Thierry Huby Philipppe Lesnik Theo H. E. Meuwissen Haja N. Kadarmideen Merete Fredholm 《PloS one》2015,10(9)
The pig is a well-known animal model used to investigate genetic and mechanistic aspects of human disease biology. They are particularly useful in the context of obesity and metabolic diseases because other widely used models (e.g. mice) do not completely recapitulate key pathophysiological features associated with these diseases in humans. Therefore, we established a F2 pig resource population (n = 564) designed to elucidate the genetics underlying obesity and metabolic phenotypes. Segregation of obesity traits was ensured by using breeds highly divergent with respect to obesity traits in the parental generation. Several obesity and metabolic phenotypes were recorded (n = 35) from birth to slaughter (242 ± 48 days), including body composition determined at about two months of age (63 ± 10 days) via dual-energy x-ray absorptiometry (DXA) scanning. All pigs were genotyped using Illumina Porcine 60k SNP Beadchip and a combined linkage disequilibrium-linkage analysis was used to identify genome-wide significant associations for collected phenotypes. We identified 229 QTLs which associated with adiposity- and metabolic phenotypes at genome-wide significant levels. Subsequently comparative analyses were performed to identify the extent of overlap between previously identified QTLs in both humans and pigs. The combined analysis of a large number of obesity phenotypes has provided insight in the genetic architecture of the molecular mechanisms underlying these traits indicating that QTLs underlying similar phenotypes are clustered in the genome. Our analyses have further confirmed that genetic heterogeneity is an inherent characteristic of obesity traits most likely caused by segregation or fixation of different variants of the individual components belonging to cellular pathways in different populations. Several important genes previously associated to obesity in human studies, along with novel genes were identified. Altogether, this study provides novel insight that may further the current understanding of the molecular mechanisms underlying human obesity. 相似文献
929.
Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux‐en‐Y gastric bypass 下载免费PDF全文
930.
Thomas Nordstr?m Kj?r Kasper Thorsen Niels Jessen Karin Stenderup Steen B?nl?kke Pedersen 《PloS one》2015,10(5)
BackgroundThe polyphenol resveratrol has anti-inflammatory effects in various cells, tissues, animals and human settings of low-grade inflammation. Psoriasis is a disease of both localized and systemic low-grade inflammation. The Sirtuin1 enzyme thought to mediate the effects of resveratrol is present in skin and resveratrol is known to down regulate NF-κB; an important contributor in the development of psoriasis. Consequently we investigated whether resveratrol has an effect on an Imiquimod induced psoriasis-like skin inflammation in mice and sought to identify candidate genes, pathways and interleukins mediating the effects.MethodsThe study consisted of three treatment groups: A control group, an Imiquimod group and an Imiquimod+resveratrol group. Psoriasis severity was assessed using elements of the Psoriasis Area Severity Index, skin thickness measurements, and histological examination. We performed an RNA microarray from lesional skin and afterwards Ingenuity pathway analysis to identify affected signalling pathways. Our microarray was compared to a previously deposited microarray to determine if gene changes were psoriasis-like, and to a human microarray to determine if findings could be relevant in a human setting.ResultsImiquimod treatment induced a psoriasis-like skin inflammation. Resveratrol significantly diminished the severity of the psoriasis-like skin inflammation. The RNA microarray revealed a psoriasis-like gene expression-profile in the Imiquimod treated group, and highlighted several resveratrol dependent changes in relevant genes, such as increased expression of genes associated with retinoic acid stimulation and reduced expression of genes involved in IL-17 dependent pathways. Quantitative PCR confirmed a resveratrol dependent decrease in mRNA levels of IL-17A and IL-19; both central in developing psoriasis.ConclusionsResveratrol ameliorates psoriasis, and changes expression of retinoic acid stimulated genes, IL-17 signalling pathways, IL-17A and IL-19 mRNA levels in a beneficial manner, which suggests resveratrol, might have a role in the treatment of psoriasis and should be explored further in a human setting. 相似文献